AiCuris
Germany - WuppertalBiotechnology
Focus: AiCuris is a German biotech focused on anti-infective therapies, specializing in viral infections with a pipeline of investigational antivirals. The company operates as a publicly-listed entity with a lean, focused development program in infectious diseases.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
5-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at AiCuris?
AI assessmentBest suited for specialists seeking deep focus in virology and early-stage development; limited for those seeking rapid career growth or product commercialization experience.
Why Work Here
- Lead early-stage antiviral development with Phase 3 candidate pritelivir for HSV infection, offering direct visibility to late-stage clinical execution
- Specialized focus on high-unmet-need viral infections (HSV, HCMV, BK virus) where competitive landscape is sparse and differentiation potential is high
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)
Urinary Tract InfectionsClinical Trials (1)
NCT02641015Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)
N/AHelp build intelligence for AiCuris
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.